[HTML][HTML] A multicenter observational study of incretin-based drugs and heart failure

…, M Dahl, CR Dormuth, KK Clemens… - … England Journal of …, 2016 - Mass Medical Soc
Background There is concern that antidiabetic incretin-based drugs, including dipeptidyl
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …

Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study

L Richard, R Booth, J Rayner, KK Clemens… - … Open Access Journal, 2021 - cmajopen.ca
Background: People with a recent history of homelessness are believed to be at high risk of
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, when …

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study

…, RW Platt, M Dahl, CR Dormuth, KK Clemens… - bmj, 2016 - bmj.com
Objective To determine whether the use of incretin based drugs compared with sulfonylureas
is associated with an increased risk of incident pancreatic cancer in people with type 2 …

Association between incretin-based drugs and the risk of acute pancreatitis

…, M Dahl, CR Dormuth, KK Clemens… - JAMA internal …, 2016 - jamanetwork.com
Importance The association between incretin-based drugs, such as dipeptidyl peptidase 4 (DPP-4)
inhibitors and glucagon-like peptide 1 (GLP-1) agonists, and acute pancreatitis is …

[HTML][HTML] High temperatures and cardiovascular-related morbidity: a scoping review

KR Cicci, A Maltby, KK Clemens… - International journal of …, 2022 - mdpi.com
The primary objective of this review was to synthesize studies assessing the relationships
between high temperatures and cardiovascular disease (CVD)-related hospital encounters (ie, …

Use of sodium–glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study

C Iskander, DZ Cherney, KK Clemens, SN Dixon… - Cmaj, 2020 - Can Med Assoc
BACKGROUND: Regulatory agencies warn about the risk of acute kidney injury (AKI) after
the initiation of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Our objective was to …

Sex disparities in cardiovascular outcome trials of populations with diabetes: a systematic review and meta-analysis

KK Clemens, M Woodward, B Neal, B Zinman - Diabetes Care, 2020 - Am Diabetes Assoc
BACKGROUND Sex differences have been described in diabetes cardiovascular outcome
trials (CVOTs). PURPOSE We systematically reviewed for baseline sex differences in …

Denosumab in chronic kidney disease: A narrative review of treatment efficacy and safety

…, T Khan, A Cowan, N Sultan, KK Clemens - Archives of …, 2021 - Springer
People with chronic kidney disease (CKD) are at high risk of bone fractures. In this review,
we summarize the complexity of fracture prevention in CKD, describe the usefulness of a …

Fracture risk of sodium-glucose cotransporter-2 inhibitors in chronic kidney disease

…, AX Garg, K Naylor, MA Weir, KK Clemens - Clinical Journal of the …, 2022 - journals.lww.com
Results After weighting, we identified a total of 38,994 new users of a SGLT2 inhibitor and
37,449 new users of a DPP-4 inhibitor and observed a total of 342 fractures at 180 days and …

[HTML][HTML] Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002-2013

KK Clemens, S Shariff, K Liu, I Hramiak, JL Mahon… - PloS one, 2015 - journals.plos.org
Background Over the last decade, several new antihyperglycemic medications have been
introduced including those associated with a lower hypoglycemia risk. We aimed to …